Erdafitinib’s latest market price reference and detailed description of drug purchase costs in 2026

Erdafitinib is an oral FGFR inhibitor, mainly used to treat patients with advanced or metastatic urothelial cancer carrying FGFR gene mutations or rearrangements. Its mechanism of action is to block tumor cell proliferation and angiogenesis by inhibiting the FGFR signaling pathway, thereby delaying disease progression. Due to its strong targeting, erdafitinib provides a new treatment option for patients with FGFR mutation-positive patients, especially for patients who are ineffective or intolerant to standard chemotherapy regimens.

In the domestic market, erdafitinib is already on the market, but it has not yet been included in medical insurance, and purchase channels are limited. If patients need to obtain drugs in China, they usually need to purchase them through large tertiary hospitals or pharmacies with import drug qualifications. However, since the drug has not been on the market for a long time, it may be difficult to purchase it directly. You need to consult a professional doctor or pharmacist in advance to ensure the source of the drug is regular and the drug is safe. The price of domestic original drugs is relatively high, probably around 20,000 yuan per box, and may fluctuate depending on specifications and procurement channels.

In the overseas market, the original drug of erdafitinib is mainly the Hong Kong version, and the price is also high. Each box sells for more than 20,000 yuan, and it needs to be purchased through regular Hong Kong pharmacies. When purchasing drugs overseas, you must comply with relevant prescription drug management regulations, including providing legal prescriptions and medical certificates to ensure that the drugs are from regular sources and are safe to use. Some patients obtain original drugs through formal overseas channels, which can be used for clinical treatment or as a bridging solution, but transportation and legal compliance issues need to be handled carefully.

In addition, there are already generic drugs available in overseas markets, such as the Laos version and the Bangladesh Yaopin International version, with relatively low prices, ranging from a few hundred yuan to more than 2,000 yuan. The ingredients of generic drugs are basically the same as those of the original drugs and can be used safely under the guidance of a doctor. When choosing generic drugs, patients should pay attention to drug quality, source legality, and monitor blood drug concentrations. They should also cooperate with regular follow-up and symptom management to ensure efficacy and safety and reduce drug cost pressure.

Keyword tags: erdafitinib, FGFR inhibitor, urothelial cancer, price, medical insurance

Reference:https://en.wikipedia.org/wiki/Erdafitinib